Poultry Vaccines Market Insights Report: Opportunities and Drivers 2030

January 28, 2026January 28, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the direct-to-consumer (d2c) brands market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Poultry Vaccines Market expected to grow between 2026 and 2030?

The poultry vaccines market size has shown significant growth over recent years. This market is anticipated to expand from $1.94 billion in 2025 to $2.12 billion in 2026, progressing at a compound annual growth rate (CAGR) of 9.4%. The expansion observed in past periods can be linked to factors such as outbreaks of avian diseases, increasing poultry consumption, the development of traditional vaccines, enhanced veterinary awareness at the farm level, and the broader expansion of commercial poultry farming.

The poultry vaccines market size is projected to experience substantial expansion over the coming years, reaching $3.04 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.5%. This anticipated growth stems from several factors, including the increasing development of recombinant and DNA vaccines, the implementation of precise poultry vaccination strategies, advancements in vaccine administration technologies, governmental efforts to promote poultry health, and an elevated emphasis on biosecurity measures within poultry farms. Key trends anticipated during this period encompass the widespread use of both live and inactivated poultry vaccines, a heightened focus on preventing diseases in both broiler and layer chickens, the broader application of recombinant and DNA vaccines, the incorporation of vaccination schedules into overall farm management, and the establishment of robust cold chain systems for distributing poultry vaccines.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Which Drivers Are Influencing Market Acceleration In The Poultry Vaccines Market?

The escalating occurrence of zoonotic diseases is expected to drive the expansion of the poultry vaccine market in the future. These diseases are a category of widespread illnesses caused by infectious microorganisms such as viruses, bacteria, parasites, and fungi. The rising incidence of zoonotic diseases is attributed to increased interaction between humans and animals, as burgeoning urbanization and livestock farming bring populations and animals into closer contact. The poultry vaccine market plays a crucial role in managing the increasing prevalence of zoonotic diseases, as heightened disease risks necessitate vaccination to prevent the transmission of infections from poultry to humans and safeguard flock health. For instance, in December 2025, the European Centre for Disease Prevention and Control, a Sweden-based government agency, reported that in 2024, the five most frequently documented zoonoses in humans included campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Consequently, the growing prevalence of zoonotic diseases is anticipated to fuel the growth of poultry vaccines.

What Segments Are Identified Within The Structure Of The Poultry Vaccines Market?

The poultry vaccines market covered in this report is segmented –

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines

2) By Disease Type: Avain Influenza, Infectious Bronchitis

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

5) By Application: Broiler, Layer, Breeder

Subsegments:

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

What Industry Trends Are Transforming The Poultry Vaccines Market?

Leading companies active in the poultry vaccine market are concentrating on developing new technological solutions to reinforce their market position. These new technological solutions refer to advanced vaccine formulations, improved delivery systems, and sophisticated diagnostic tools, all designed to enhance disease prevention, overall effectiveness, and the management of poultry health. For instance, in October 2023, Zoetis Inc., a US-based animal health company, introduced Circomax. This porcine circovirus type 2 (PCV2) vaccine is available in two genotypes, a and b. The vaccination aims to defend against PCV2 risks, such as the three genotypes prevalent in the UK pig herd, and to provide broader coverage. It is the only PCV2 vaccination licensed to offer protection against all three genotypes, having demonstrated efficacy against PCV2a, PCV2b, and PCV2d. With the launch of CircoMax, Zoetis endeavors to anticipate the evolution of PCV2 genotypes and deliver high levels of efficacy, convenience, and proven safety for healthy piglets.

Which Major Firms Are Strengthening Their Position In The Poultry Vaccines Market?

Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Poultry Vaccines Market?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Poultry Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8622&type=smp

Browse Through More Reports Similar to the Global Poultry Vaccines Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Chickenpox Vaccine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795